Novel iridium (III)-derived organometallic compound for the inhibition of human platelet activation

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Phospholipase 100%
• Organometallic Compound 100%
• Neoplasm 100%
• Protein Kinase C 100%
• Side Effect 50%
• Phosphotransferase 50%
• Mitogen Activated Protein Kinase P38 50%
• Mitogen Activated Protein Kinase 50%
• Transition Element 50%
• Cisplatin 50%
• Thrombin 50%
• 9 (Tetrahydro 2 Furyl)adenine 50%
• Artery Thrombosis 50%
• Anticoagulant Agent 50%
• 1h 1,2,4 oxadiazolo[4,3 A]quinoxalin 1 One 50%
• Antithrombocytic Agent 50%
• Adenylate Cyclase Inhibitor 50%
• Thromboembolism 50%
• Guanylate Cyclase Inhibitor 50%
• Phorbol 12,13-dibutyrate 50%
• P-Selectin 50%
• Fenton Reaction 50%
• Platinum Derivative 50%
• Iridium Complex 50%
• Disease 50%
• Protein C 50%
• Protein Kinase B 50%
• Adenosine 50%